谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

DREAMM-2: Single-agent belantamab mafodotin (belamaf; GSK2857916) in patients with relapsed/refractory multiple myeloma (RRMM) - outcomes by prior therapies

K. Weisel,S. Lonial,H. Lee,A. Badros,S. Trudel,A. Nooka,A. Chari,A-O Abdallah,N. Callander,D. Sborov,A. Suvannasankha, P. Vorhees,J. Opalinska,A. Hoos,E. Zhi,J. Baron,T. Piontek,R. Jewell,I Gupta,A. Cohen

ONCOLOGY RESEARCH AND TREATMENT（2020）

引用 0|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要